Cargando…

miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1

Detalles Bibliográficos
Autores principales:	Li, An, Zhao, Lifen, Li, Nana, Miao, Yuan, Zhou, Huimin, Jia, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448068/ https://www.ncbi.nlm.nih.gov/pubmed/30896876 http://dx.doi.org/10.3892/or.2019.7057

Ejemplares similares

Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia
por: Zhao, Lifen, et al.
Publicado: (2016)

Corrigendum to “Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis”
por: Wang, Wenjing, et al.
Publicado: (2021)

BCR‐ABL exon 7 deletion and novel point mutation in patient with chronic myelogenous leukemia
Publicado: (2019)

MiR-570 inhibits cell proliferation and glucose metabolism by targeting IRS1 and IRS2 in human chronic myelogenous leukemia
por: Zhao, Hong, et al.
Publicado: (2017)

The targeting of MTDH by miR-145-5p or miR-145-3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells
por: Pan, Dong, et al.
Publicado: (2023)

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
por: Liu, Shaoqing, et al.
Publicado: (2022)

Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320
por: Gao, Xiaotong, et al.
Publicado: (2019)

Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017)

Co-expression Pattern Analysis of miR-17-92 Target Genes in Chronic Myelogenous Leukemia
por: Wang, Fengfeng, et al.
Publicado: (2016)

Bone Marrow Niche Trafficking of miR-126 Controls Self-Renewal of Leukemia Stem Cells in Chronic Myelogenous Leukemia
por: Zhang, Bin, et al.
Publicado: (2018)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

Downregulation of miR-142a Contributes to the Enhanced Anti-Apoptotic Ability of Murine Chronic Myelogenous Leukemia Cells
por: Chen, Zhiwei, et al.
Publicado: (2021)

miR-181a Post-Transcriptionally Downregulates Oncogenic RalA and Contributes to Growth Inhibition and Apoptosis in Chronic Myelogenous Leukemia (CML)
por: Fei, Jia, et al.
Publicado: (2012)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)

MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
por: Li, Nana, et al.
Publicado: (2017)

Corrigendum to “the long noncoding RNA MEG3 and its target miR-147 regulate JAK/STAT pathway in advanced chronic myeloid leukemia” [EBioMedicine 35 (2018) 61–75]
por: Li, Zi-ye, et al.
Publicado: (2018)

Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P-gp and MRP-1
por: Yi, Ying-Jie, et al.
Publicado: (2023)

miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1
por: Xu, Juan, et al.
Publicado: (2017)

Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells
por: Taverna, Simona, et al.
Publicado: (2014)

Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype via exosomal miR-21
por: Taverna, Simona, et al.
Publicado: (2016)

miR-199b-5p serves as a tumor suppressor in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018)

miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer
por: Ning, Tao, et al.
Publicado: (2022)

[Corrigedum] miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling
por: Lei, Zhengwen, et al.
Publicado: (2023)

miR–9-5p regulates immunometabolic and epigenetic pathways in β-glucan–trained immunity via IDH3α
por: Su, Haibo, et al.
Publicado: (2022)

RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia
por: Gu, Chunming, et al.
Publicado: (2016)

Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4
por: Ma, Xiaolu, et al.
Publicado: (2016)

[Corrigendum] Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids
por: Zhang, Ye, et al.
Publicado: (2023)

miR-23a suppresses pancreatic cancer cell progression by inhibiting PLK-1 expression
por: Chen, Bin, et al.
Publicado: (2022)

SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153
por: Ma, Yawen, et al.
Publicado: (2022)

Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012)

Chronic myelogenous leukemia on target
por: Némethová, Veronika, et al.
Publicado: (2018)

Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR-367/PTEN axis
por: Mu, Xin, et al.
Publicado: (2022)

[Corrigendum] DNA methylation is involved in the aberrant expression of miR‑133b in colorectal cancer cells
por: Lv, Lv, et al.
Publicado: (2023)

Corrigendum to “miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1”
por: Wang, Hao, et al.
Publicado: (2021)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

Corrigendum to “miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1”
por: Jia-yuan, Xu, et al.
Publicado: (2020)

Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
por: Wang, Yu, et al.
Publicado: (2023)

High glucose promotes hepatic fibrosis via miR-32/MTA3-mediated epithelial-to-mesenchymal transition
por: Li, Qiang, et al.
Publicado: (2022)

[Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
por: Pei, Yuqing, et al.
Publicado: (2023)

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sns35j9cc5khfn75agsngtqjcs